Concepedia

Improved Oral Bioavailability and Liver Targeting of Sorafenib Solid Lipid Nanoparticles in Rats

Haipeng Wang, Huiyun Wang, Wenlong Yang, Mengjie Yu, Shuilin Sun, Baogang Xie

AAPS PharmSciTech · 2017 · 36 citations · 20 references

DOI

Concepts

References

20

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

, , +11

Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs

Liandong Hu, Xing Tang, Fude Cui · Journal of Pharmacy and Pharmacology · 2004 · 276 citations · Full text

, , +17

Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics

Chetan Lathia, John Lettieri, Frank Cihon et al. · Cancer Chemotherapy and Pharmacology · 2005 · 208 citations

, , +10

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry

Amina Haouala, Boris Zanolari, Bertrand Rochat et al. · Journal of Chromatography B · 2009 · 202 citations

, , +16

Cyclosporine-loaded solid lipid nanoparticles (SLN®): Drug–lipid physicochemical interactions and characterization of drug incorporation

R.H. Müller · European Journal of Pharmaceutics and Biopharmaceutics · 2007 · 197 citations

, , +16